Fresenius Medical Care AG KGaA Total Long Term Liabilities 2010-2024 | FMS

Fresenius Medical Care AG KGaA total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Fresenius Medical Care AG KGaA total long term liabilities for the quarter ending September 30, 2024 were $13.009B, a 11.99% decline year-over-year.
  • Fresenius Medical Care AG KGaA total long term liabilities for 2023 were $14.061B, a 3.56% decline from 2022.
  • Fresenius Medical Care AG KGaA total long term liabilities for 2022 were $14.579B, a 6.15% decline from 2021.
  • Fresenius Medical Care AG KGaA total long term liabilities for 2021 were $15.534B, a 3.04% increase from 2020.
Fresenius Medical Care AG KGaA Annual Total Long Term Liabilities
(Millions of US $)
2023 $14,061
2022 $14,579
2021 $15,534
2020 $15,076
2019 $14,224
2018 $8,352
2017 $8,926
2016 $10,440
2015 $10,720
2014 $11,875
2013 $9,433
2012 $9,425
2011 $6,799
2010 $5,501
2009 $6,182
Fresenius Medical Care AG KGaA Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $13,009
2024-06-30 $13,755
2024-03-31 $14,114
2023-12-31 $14,061
2023-09-30 $14,781
2023-06-30 $14,618
2023-03-31 $14,793
2022-12-31 $14,579
2022-09-30 $15,424
2022-06-30 $14,625
2022-03-31 $15,495
2021-12-31 $15,534
2021-09-30 $15,203
2021-06-30 $15,363
2021-03-31 $15,330
2020-12-31 $15,076
2020-09-30 $15,606
2020-06-30 $14,098
2020-03-31 $13,459
2019-12-31 $14,224
2019-09-30 $13,619
2019-06-30 $13,414
2019-03-31 $13,361
2018-12-31 $8,352
2018-09-30 $8,360
2018-06-30 $9,029
2018-03-31 $9,609
2017-12-31 $8,926
2017-09-30 $9,557
2017-06-30 $9,584
2017-03-31 $9,703
2016-12-31 $10,440
2016-09-30 $10,167
2016-06-30 $10,804
2016-03-31 $10,811
2015-12-31 $10,720
2015-09-30 $11,237
2015-06-30 $11,362
2015-03-31 $11,183
2014-12-31 $11,875
2014-09-30 $9,432
2014-06-30 $10,136
2014-03-31 $9,663
2013-12-31 $9,433
2013-09-30 $9,406
2013-06-30 $9,271
2013-03-31 $8,942
2012-12-31 $9,425
2012-09-30 $9,069
2012-06-30 $6,861
2012-03-31 $6,965
2011-12-31 $6,799
2011-09-30 $6,718
2011-06-30 $7,207
2011-03-31 $6,769
2010-12-31 $5,501
2010-09-30 $5,457
2010-06-30 $4,024
2010-03-31 $4,725
2009-12-31 $6,182
2009-09-30 $6,341
2009-06-30 $6,141
2009-03-31 $5,625
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $13.538B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.066B 26.11
Intuitive Surgical (ISRG) United States $211.086B 110.36
Alcon (ALC) Switzerland $41.615B 27.84
Edwards Lifesciences (EW) United States $41.156B 26.14
IQVIA Holdings (IQV) United States $35.821B 19.74
IDEXX Laboratories (IDXX) United States $34.331B 40.43
DexCom (DXCM) United States $32.958B 49.63
Waters (WAT) United States $23.988B 35.47
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.710B 0.00
Hologic (HOLX) United States $15.740B 17.09
Globus Medical (GMED) United States $12.364B 31.31
Sysmex ADR (SSMXY) Japan $11.726B 0.00
Penumbra (PEN) United States $10.120B 99.13
Masimo (MASI) United States $9.225B 44.63
Glaukos (GKOS) United States $8.623B 0.00
Teleflex (TFX) United States $8.419B 13.43
Integer Holdings (ITGR) United States $4.729B 26.81
Inari Medical (NARI) United States $4.657B 0.00
PROCEPT BioRobotics (PRCT) United States $3.967B 0.00
Veracyte (VCYT) United States $3.145B 94.37
Nihon Kohden (NHNKY) Japan $2.658B 20.19
LivaNova (LIVN) United Kingdom $2.623B 15.14
Tandem Diabetes Care (TNDM) United States $2.309B 0.00
Elekta AB (EKTAY) Sweden $2.167B 19.48
TransMedics (TMDX) United States $1.920B 60.85
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
Alphatec Holdings (ATEC) United States $1.641B 0.00
Artivion (AORT) United States $1.288B 85.33
RxSight (RXST) United States $1.225B 0.00
Pulse Biosciences (PLSE) United States $1.083B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.911B 0.00
AxoGen (AXGN) United States $0.796B 0.00
Mesa Laboratories (MLAB) United States $0.758B 17.88
IRadimed (IRMD) United States $0.750B 40.53
AVANOS MEDICAL, INC (AVNS) United States $0.732B 12.44
SiBone (SIBN) United States $0.700B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.693B 0.00
OrthoPediatrics (KIDS) United States $0.658B 0.00
Semler Scientific (SMLR) United States $0.599B 31.55
Treace Medical Concepts (TMCI) United States $0.543B 0.00
AngioDynamics (ANGO) United States $0.503B 0.00
Delcath Systems (DCTH) United States $0.458B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
CVRx (CVRX) United States $0.428B 0.00
Tactile Systems Technology (TCMD) United States $0.418B 22.60
ClearPoint Neuro (CLPT) United States $0.415B 0.00
NeuroPace (NPCE) United States $0.357B 0.00
Alpha Tau Medical (DRTS) Israel $0.273B 0.00
Inogen (INGN) United States $0.249B 0.00
Accuray (ARAY) United States $0.225B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.171B 0.00
Sight Sciences (SGHT) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.108B 11.51
Atossa Genetics (ATOS) United States $0.104B 0.00
908 Devices (MASS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Neuronetics (STIM) United States $0.075B 0.00
WORK Medical Technology Group (WOK) China $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
InspireMD (NSPR) Israel $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.93
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.033B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.008B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00